Premonitory symptoms in migraine: A REFORM Study
Janu Thuraiaiyah, Håkan Ashina, Rune Häckert Christensen, Haidar M. Al‐Khazali, Astrid Wiggers, Faisal Mohammad Amin, Timothy J. Steiner, Messoud Ashina
Abstract
Background Estimates of proportions of people with migraine who report premonitory symptoms vary greatly among previous studies. Our aims were to establish the proportion of patients reporting premonitory symptoms and its dependency on the enquiry method. Additionally, we investigated the impact of premonitory symptoms on disease burden using Headache Impact Test (HIT-6), Migraine Disability Assessment (MIDAS) and World Health Organization Disability Assessment 2.0 (WHODAS 2.0), whilst investigating how various clinical factors influenced the likelihood of reporting premonitory symptoms. Methods In a cross-sectional study, premonitory symptoms were assessed among 632 patients with migraine. Unprompted enquiry was used first, followed by a list of 17 items (prompted). Additionally, we obtained clinical characteristics through a semi-structured interview. Results Prompted enquiry resulted in a greater proportion reporting premonitory symptoms than unprompted (69.9% vs. 43.0%; p < 0.001) and with higher symptom counts (medians 2, interquartile range = 0–6 vs. 1, interquartile range = 0–1; p < 0.001). The number of symptoms correlated weakly with HIT-6 ( ρ = 0.14; p < 0.001) and WHODAS scores ( ρ = 0.09; p = 0.041). Reporting postdromal symptoms or triggers increased the probability of reporting premonitory symptoms, whereas monthly migraine days decreased it. Conclusions The use of a standardized and optimized method for assessing premonitory symptoms is necessary to estimate their prevalence and to understand whether and how they contribute to disease burden.